Strongbridge Biopharma Profile

5.95
USD 0.17  2.86%
5.95Last Month High 7.5 
5.85Trading Day  High 6.2 

Strongbridge Biopharma Summary

Strongbridge Biopharma plc (SBBP) is traded on NASDAQ in USA. It is located in PENNSYLVANIA, U.S.A and employs 10 people. Strongbridge Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 220.84 M. Strongbridge Biopharma plc has 35.34 M outstanding shares of which 747.66 K shares are at this time shorted by private and institutional investors with about 10.35 trading days to cover. Strongbridge Biopharma plc currently holds about 33.86 M in cash with (39.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96.
Check Strongbridge Biopharma Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Strongbridge Biopharma plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Strongbridge Biopharma Against Markets

Current Ratings  

Strongbridge Biopharma 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 12% 
Strongbridge Biopharma plc, a biopharmaceutical company, focuses on the development, inlicensing, acquisition, and commercialization of various complementary solutions and product candidates that target rare diseases. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameStrongbridge Biopharma plc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationPENNSYLVANIA, U.S.A
Business AddressTrevose, PA
ExchangeNASDAQ
CUSIPG85347105
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.strongbridgebio.com
Contact Number610 254 9200
CurrencyUSD - US Dollar

Recommendations

Strongbridge Biopharma Analyst Recommendations
Target PriceAdvice# of Analysts
17.33Strong Buy3Odds
Strongbridge Biopharma plc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Strongbridge Biopharma Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Strongbridge Biopharma Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.32March 23, 2017
Strongbridge Biopharma plc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate